Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
52.52
-1.31 (-2.43%)
At close: Mar 6, 2026, 4:00 PM EST
54.16
+1.64 (3.12%)
After-hours: Mar 6, 2026, 7:59 PM EST

Moderna Revenue by Segment

Period Ending Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Product Sales
1.82B 2.11B 2.96B 3.03B 3.11B 4.96B 4.90B 5.01B - - -
Product Sales Growth
-41.52% -57.47% -39.64% -39.56% -53.40% -43.42% -51.65% -65.15% - - -
Grant and Collaboration
126.00M 121.00M 120.00M 149.00M 145.00M 191.00M 200.00M - 177.00M
Grant and Collaboration Growth
-13.10% -36.65% -40.00% -15.82% -62.24% -65.52% -72.26% - -78.62%

Product Sales by Geography

Period Ending Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022
Europe
1.20B - - 1.29B 1.06B - - 1.35B 2.96B 3.90B 5.23B 6.73B
Europe Growth
-59.36% - - -66.94% -79.78% - - -79.90% - - - -
United States
1.15B 1.58B 1.66B 1.73B 2.28B 1.98B 1.82B 1.72B
United States Growth
-49.58% -20.01% -8.91% 0.35% 17.52% -1.69% -47.44% -60.95%
Rest of World
653.00M 802.00M 798.00M 810.00M 1.79B 2.21B 2.41B 3.60B
Rest of World Growth
-63.48% -63.63% -66.94% -77.49% -53.39% -47.31% -57.24% -50.70%

Operating Expense Breakdown

Period Ending Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Research and Development
3.13B 3.48B 3.82B 4.34B 4.54B 4.83B 4.85B 4.78B
Research and Development Growth
-31.06% -27.93% -21.34% -9.23% -6.23% 3.81% 12.53% 23.37%
Selling, General, and Administrative
1.02B 1.06B 1.07B 1.11B 1.17B 1.29B 1.45B 1.52B
Selling, General, and Administrative Growth
-13.29% -17.94% -26.13% -26.75% -24.21% -11.07% 12.71% 29.85%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.